Sundrug CoTSE:9989 +0.68%79 Interest Coverage is 82.38 as of Mar. 2026, which is 98% below its 10-year median of 4,020.41. GuruFocus rates TSE:9989 with a GF Score™ of 79/100 and a GF Value™ of 円4,719.27 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 452 Healthcare Providers & Services companies, Sundrug Co ranks better than 85.62% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sundrug Co's
Operating Income
for the
three
months ended in Mar. 2026 was 円10,298 Mil. Sundrug Co's Interest Expense for the
three
months ended in Mar. 2026 was 円-125 Mil.
Sundrug Co's interest coverage for the quarter that ended in Mar. 2026 was 82.38.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sundrug Co's Interest Coverage or its related term are showing as below:
TSE:9989'
s Interest Coverage Range Over the Past 10 Years
Min: 121.97 Med: 4020.41 Max: 6224.83
Current: 121.97
TSE:9989's Interest Coverage is ranked better than 85.62% of 452
companies
in the Healthcare Providers & Services industry
Industry Median: 7.99
vs TSE:9989: 121.97
Sundrug Co (TSE:9989) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sundrug Co Interest Coverage Related Terms
Sundrug Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Sundrug Co Interest Coverage Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sundrug Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co (TSE:9989) has a Interest Coverage of 82.38 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sundrug Co and its competitors. This is 98% below median its historical median of 4,020.41. Over the past decade, Sundrug Co's Interest Coverage has ranged from 121.97 to 6,224.83. According to the industry distribution chart, Sundrug Co ranks #65 out of 452 companies in the Healthcare Providers & Services industry, placing it in the top 14.4%.
Is Sundrug Co's Interest Coverage too high?
Sundrug Co's current Interest Coverage of 82.38 is 98% below median its 10-year median of 4,020.41. Over the past 10 years, this metric has ranged from a low of 121.97 to a high of 6,224.83. The Healthcare Providers & Services industry median Interest Coverage is 7.99. Sundrug Co's value of 82.38 is 931% above this industry median. Based on the distribution chart, Sundrug Co ranks #65 out of 452 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sundrug Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Interest Coverage compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #65 out of 452 companies for Interest Coverage. This places Sundrug Co in the top 14% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.99. Sundrug Co's value of 82.38 is 931% above this benchmark. Historically, Sundrug Co's own Interest Coverage has ranged from 121.97 to 6,224.83 over the past decade. While the company's 10-year median is 4,020.41 vs. the industry median of 7.99, Sundrug Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.99, based on 452 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Interest Coverage of 82.38 is 931% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Interest Coverage is 82.38, which is 98% below median its own 10-year median of 4,020.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Based on GuruFocus' analysis, Sundrug Co (TSE:9989) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,719.27, compared to a current price of 円3,833.00 — trading 18.8% below its estimated fair value. The current Interest Coverage is 82.38, which is 98% below median its 10-year median of 4,020.41 and 931% above the Healthcare Providers & Services industry median of 7.99. Sundrug Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sundrug Co (TSE:9989), the current Interest Coverage is 82.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (TSE:9989) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of 円3,833.00 is trading 18.8% below its estimated GF Value™ of 円4,719.27.
GuruFocus considers Sundrug Co to be Modestly Undervalued.
Key valuation signals for TSE:9989:
Interest Coverage: 82.38 (98% below median its 10-year median of 4,020.41)
GF Value™: 円4,719.27 vs. price of 円3,833.00 (18.8% below fair value)
Industry Position: 931% above the Healthcare Providers & Services median (#65 of 452)
No single metric tells the full story. See the TSE:9989 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
79GF Score
Get the complete analysis for TSE:9989
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9989 has been successfully added to your 
